Shopping Cart 0
Cart Subtotal
USD 0

Global Insulin Pumps Industry (China-specific Market Assessment) - Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018-2024

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 3500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 4000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 5000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Insulin Pumps Industry (China-specific Market Assessment)-Drivers, Restraints, Opportunities, Trends, and Forecasts: 2018-2024

Overview: An insulin pump is a device that contains a cartridge of rapid-acting insulin. Insulin infusion pumps work as an alternative to the traditional system of daily injections or an insulin pen. These reduce large swings in blood glucose level, deliver insulin more accurately when compared to injections, scheduling of meal timings is not required, and are less painful. These user-friendly properties of insulin pumps are making patients shift toward the use of infusion pumps.

According to the WHO estimates, the number of people with diabetes has increased from 108 million in 1980 to 422 million in 2014. The market for insulin pumps is growing due to increase in the number of diabetes cases among all age groups. The demand for insulin pumps is high due to varied features and functionalities.

The insulin pumps market has been segmented into traditional insulin pumps, disposable insulin pumps, smart pumps, insulin reservoirs, insulin infusion sets, and other devices. North America is leading with technological innovations, followed by Europe and Asia Pacific. Asia Pacific is expected to witness rapid growth during the forecast period due to increased incidence of diabetes in the region. However, the high cost of infusion pumps, development of oral insulin, and insulin aerosols in the form of inhalers can pose a challenge to the insulin pumps market in future.

Effects of Diabetes:

Nearly 3.5 million people die annually due to complications related to high blood sugar. Some of the adverse effects of diabetes are as follows:

High risk of heart diseases and stroke.

High risk for diabetic retinopathy.

Increased risk of kidney failure; about 10-20% diabetics die due to renal failure.

Individuals with diabetes often suffer from untreated anemia, which leads to fatigue and other health-related complications.

Incidence and Prevalence:

Diabetes is one of the most prominent non-communicable diseases prevailing globally. According to the seventh edition of IDF Atlas, in 2015, there were 415 million people with diabetes (aged 20-79 years), and the number is expected to reach 642 million by 2040.

Prevalence of Diabetes Population Forecasting by Region

Region 2015 (in millions) 2040 (in millions)

North America and the Caribbean 44 61

South and Central America 30 49

Europe 60 71

Middle East and North Africa 35 72

Rest of Africa 14 34

South East Asia 78 140

Western Pacific 158 215

Market Analysis: The global insulin pumps market is estimated to witness a CAGR of 9.7% during the forecast period 2018-2024. Increased prevalence of diabetes, growing popularity of advanced insulin pumps, and the introduction of new technologies are driving the market growth. The market is analyzed based on three segments, namely product types, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America is set to be the leading region for the insulin pumps market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. The emerging markets have a high potential to grow owing to an increase in patient population and focus toward healthcare infrastructure.

The insulin pumps market has the lowest penetration in emerging regions, and most of the vendors are targeting India, Thailand, Indonesia, and Vietnam. These countries are the major revenue contributors in the APAC region. A higher incidence of obesity will fuel the market expansion, which will result in the high prevalence of diabetes. Around 114.1 million people in China are suffering from diabetes (type 1 & type 2), among which type 2 diabetes is more prevalent. China lacks innovative technologies and access to current trends in diabetes management, which further adds to the growth of diabetic population in the region. However, the high cost of insulin pumps, expensive consumables cost, lack of proper reimbursement policies, lack of awareness about insulin pumps in developing countries will have a significant impact on the overall market growth.

Product Analysis: Tethered insulin pump is dominating with more than 70% of the market share. Tethered insulin pumps have a long flexible tube and are the most common pumps used among diabetic patients. Increasing aging population, rise in prevalence of diabetes, need for early prevention of diseases, and growing awareness about a healthy lifestyle are expected to drive the market growth. The high cost of insulin pumps is the primary concern and challenge to the market. Many insurance providers do not have complete reimbursement for insulin pumps, and the usage of these pumps is subjective to the insurance provider in most of the developed countries. An insulin pump is cost-effective only if it is covered under health insurance.

Key Players: Insulet Corp., Medtronic plc, MicroPort Scientific Corp., F. Hoffmann-La Roche (Roche) Ltd., Tandem Diabetes Care, and other predominate & niche players.

Competitive Analysis: The insulin pumps market is highly fragmented and has immense growth opportunities for vendors, especially in developing regions. The market has the presence of many global, regional, and local players with strong competition among each other.

Benefits: The report provides complete details about the usage and adoption rate of insulin pumps for the treatment of diabetes. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, and government initiatives toward insulin pumps in the upcoming years along with details of the pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders in order to expand their business and capture the revenue in specific verticals, and to analyze before investing or expanding the business in this market.

Key Stakeholders:

READ MORE

Table Of Content

Scope

Table of Contents

1 Industry Outlook 10

1.1 Patient Demographics 12

1.2 Healthcare Spending in the US 14

1.3 Definition: Insulin Pump 14

1.4 Diabetic Overview 15

1.5 Insulin Pump Definition-Infoholic Research 15

1.6 Importance of Insulin Pump 16

1.7 Industry Trends 16

1.8 Pest Analysis 17

2 Report Outline 18

2.1 Report Scope 18

2.2 Report Summary 18

2.3 Research Methodology 19

2.4 Report Assumptions 19

3 Market Snapshot 21

3.1 Total Addressable Market (TAM) 21

3.2 Segmented Addressable Market (SAM) 23

3.3 China Insulin Pump Market 26

3.4 Healthcare in China 27

3.5 Competitive Scenario 29

3.6 Related Markets 30

3.6.1 Ultrasound Devices 30

3.6.2 Medical X-ray Equipment 30

3.6.3 MRI Equipment 30

3.7 Porter 5(Five) Forces 31

4 Market Characteristics 32

4.1 Evolution 32

4.2 Insulin Pumps Therapy Advantages 33

4.3 Insulin Pumps Therapy Disadvantages 33

4.4 Role of Insulin Pumps in Healthcare 33

4.5 Market Dynamics 34

4.5.1 Drivers 34

4.5.1.1 Huge Surge in Aging Population 34

4.5.1.2 Increase in Awareness 35

4.5.1.3 Increasing Number of Diabetic Patients 35

4.5.1.4 Rising Incidences of Government Initiatives 35

4.5.2 Opportunities 36

4.5.2.1 Technological advances in insulin pump 36

4.5.2.2 Insulin Pumps replacing traditional Methods 36

4.5.2.3 Increasing partnership and collaboration activities 36

4.5.2.4 Focus on early diabetes management 36

4.5.2.5 Rapid growth in emerging countries 37

4.5.3 Restraints 37

4.5.3.1 High price of latest insulin pumps 37

4.5.3.2 Unfavorable reimbursement plans 37

4.5.3.3 Availability of substitutes 38

4.5.3.4 Competition among major vendors 38

4.5.4 DRO-Impact Analysis 38

4.5.5 Key Stakeholders 40

5 Types: Market Size and Analysis 41

5.1 Overview 41

5.2 Tethered insulin pump 42

5.3 Untethered insulin pumps 42

5.4 Implantable insulin pump 42

6 End User: Market Size and Analysis 43

6.1 Overview 43

6.2 Hospitals 44

6.3 Homecare 44

6.4 Clinics 44

6.5 Others (nursing homes and medical offices) 44

7 Regions: Market Size and Analysis 46

7.1 Overview 46

7.2 North America 47

7.3 Europe 49

7.4 APAC 50

7.5 Rest of the World 51

8 Market Attractiveness 54

8.1 Market Attractiveness by Products 54

8.2 Market Attractiveness by End Users 55

9 Competitive Landscape 57

9.1 Overview 57

10 Product Matrix 58

11 Vendor Profiles 60

11.1 Insulet Corp. 60

11.1.1 Overview 60

11.1.2 Business Unit 63

11.1.3 Geographic Presence 63

11.1.4 Business Focus 64

11.1.5 SWOT Analysis 64

11.1.6 Business Strategy 65

11.2 Medtronic Plc 66

11.2.1 Overview 66

11.2.2 Business Unit 75

11.2.3 Geographic Presence 77

11.2.4 Business Focus 77

11.2.5 SWOT Analysis 78

11.2.6 Business Strategy 78

11.3 MicroPort Scientific Corporation 79

11.3.1 Overview 79

11.3.2 Business Units 81

11.3.3 Geographic Presence 82

11.3.4 Business Focus 82

11.3.5 SWOT Analysis 83

11.3.6 Business Strategies 84

11.4 F.Hoffmann-La Roche Ltd 85

11.4.1 Overview 85

11.4.2 Business Unit 90

11.4.3 Geographic Presence 90

11.4.4 Business Focus 91

11.4.5 SWOT Analysis 91

11.4.6 Business Strategy 92

11.5 Tandem Diabetes Care, Inc 93

11.5.1 Overview 93

11.5.2 Business Focus 96

11.5.3 SWOT Analysis 96

11.5.4 Business Strategy 96

12 Companies to Watch For 97

12.1 Eli Lilly and Company 97

12.1.1 Overview 97

12.2 Animas Corp. 98

12.2.1 Overview 98

12.3 Sooil Development Co., Ltd. 100

12.3.1 Overview 100

12.4 Ypsomed Holding AG 101

12.4.1 Overview 101

12.5 Valeritas, Inc 102

12.5.1 Overview 102

12.6 GlySens ICGM 103

12.6.1 Overview 103

Annexure 104

12.7 Abbreviations 104


List Of Figure

Charts

CHART 1 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION 10

CHART 2 AGING DEMOGRAPHIC GROWTH 12

CHART 3 US POPULATION DISTRIBUTION BY AGE (US, CENSUS BUREAU, CMS 2015) 13

CHART 4 US HEALTHCARE CONSUMPTION BY AGE (US, CENSUS BUREAU, CMS 2015) 13

CHART 5 WORLD POPULATION AGED 65 YEARS AND ABOVE, 1960-2060 (%) 14

CHART 6 PEST ANALYSIS OF WORLDWIDE AND CHINA INSULIN PUMPS MARKET 17

CHART 7 RESEARCH METHODOLOGY OF WORLDWIDE AND CHINA INSULIN PUMPS MARKET 19

CHART 8 DIABETES CARE DEVICES MARKET SEGMENTATION 21

CHART 9 WORDWIDE DIABETIC POPULATION BY REGION IN 2017-2045 (AGED 20-79 YEARS) 23

CHART 10 WORLDWIDE AND CHINA INSULIN PUMPS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 25

CHART 11 WORLDWIDE AND CHINA INSULIN PUMPS MARKET BY SEGMENTATION 25

CHART 12 CHINA INSULIN PUMPS MARKET REVENUE FORECAST, 2017-2024 (USD MILLION) 26

CHART 13 NUMBER OF MEDICAL INSTITUTIONS IN CHINA 2015 28

CHART 14 PORTER 5 FORCES ON WORLDWIDE AND CHINA INSULIN PUMPS MARKET 31

CHART 15 INSULIN PUMP ORGANISATION 32

CHART 16 DRO-IMPACT ANALYSIS OF WORLDWIDE AND CHINA INSULIN PUMP MARKET 38

CHART 17 KEY STAKEHOLDERS 40

CHART 18 WORLDWIDE AND CHINA INSULIN PUMPS MARKET BY TYPE SEGMENTATION, 2017 (%) 41

CHART 19 WORLDWIDE AND CHINA INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2017 (%) 43

CHART 20 WORLDWIDE AND CHINA INSULIN PUMPS MARKET BY END-USER SEGMENTATION, 2024 (%) 43

CHART 21 WORLDWIDE AND CHINA INSULIN PUMPS MARKET BY GEOGRAPHICAL SEGMENTATION, 2017 (%) 46

CHART 22 WORLDWIDE AND CHINA INSULIN PUMP MARKET BY GEOGRAPHICAL SEGMENTATION, 2024(%) 46

CHART 23 INSULIN PUMPS MARKET REVENUE IN NORTH AMERICA, 2017-2024 (USD MILLION) 47

CHART 24 INSULIN PUMPS MARKET REVENUE IN THE EUROPE REGION, 2017-2024 (USD MILLION) 49

CHART 25 INSULIN PUMPS MARKET REVENUE IN THE APAC REGION, 2016-2023 (USD MILLION) 50

CHART 26 INSULIN PUMPS MARKET REVENUE IN ROW REGION, 2017-2024 (USD MILLION) 52

CHART 27 WORLDWIDE AND CHINA INSULIN PUMPS MARKET SEGMENTATION BY GEOGRAPHY, 2017-2024 (USD MILLION) 53

CHART 28 GLOBAL NURSE CALL SYSTEMS MARKET SEGMENTATION BY GEOGRAPHY, 2016-2023 (% SHARE) 53

CHART 29 MARKET ATTRACTIVENESS BY TOP PRODUCTS TYPES 54

CHART 30 MARKET ATTRACTIVENESS BY END-USERS 55

CHART 31 INSULET CORP.: OVERVIEW SNAPSHOT 62

CHART 32 INSULET CORP.: BUSINESS UNITS 63

CHART 33 INSULET CORP.: GEOGRAPHIC PRESENCE 63

CHART 34 INSULET CORP.: SWOT ANALYSIS 64

CHART 35 MEDTRONIC PLC: OVERVIEW SNAPSHOT 74

CHART 36 MEDTRONIC PLC: BUSINESS UNITS 75

CHART 37 MEDTRONIC PLC: GEOGRAPHICAL PRESENCE 77

CHART 38 MEDTRONIC PLC: SWOT ANALYSIS 78

CHART 39 MICROPORT SCIENTIFIC CORPORATION: OVERVIEW SNAPSHOT 81

CHART 40 MICROPORT SCIENTIFIC CORPORATION: BUSINESS UNITS 81

CHART 41 MICROPORT SCIENTIFIC CORPORATION: GEOGRAPHIC PRESENCE 82

CHART 42 MICROPORT SCIENTIFIC CORPORATION: SWOT ANALYSIS 83

CHART 43 F. HOFFMANN-LA ROCHE: OVERVIEW SNAPSHOT 88

CHART 44 F. HOFFMANN.LA ROCHE.: BUSINESS UNITS 90

CHART 45 F. HOFFMANN-LA ROCHE GEOGRAPHICAL PRESENCE 90

CHART 46 F. HOFFMANN-LA ROCHE: SWOT ANALYSIS 91

CHART 47 TANDEM DIABETES CARE, INC: OVERVIEW SNAPSHOT 94

CHART 48 TANDEM DIABETES CARE, INC: SWOT ANALYSIS 96

CHART 49 ANIMAS CORP.: OVERVIEW SNAPSHOT 100


List Of Table

Tables

TABLE 1 PREVALENCE OF DIEBETES POPULATION FORECASTING BY REGION 15

TABLE 2 INSULIN PUMPS PRICING 2015 24

TABLE 3 CONSUMABLES PRICING 24

TABLE 1 DRO (CHINA) 29

TABLE 2 ESTIMATED PERCENTAGE INCREASE IN AGING POPULATION 2015-2035 34

TABLE 3 INSULIN PUMPS PRICING 37

TABLE 4 WORLDWIDE AND CHINA INSULIN PUMPS MARKET BY END-USERS 45

TABLE 5 WORLDWIDE AND CHINA INSULIN PUMPS MARKET REVENUE BY REGIONS, 2017-2024 (USD MILLION) 47

TABLE 6 DRO: NORTH AMERICA 48

TABLE 7 DRO (EUROPE) 50

TABLE 8 DRO: APAC 51

TABLE 9 DRO: ROW 53

TABLE 10 WORLDWIDE AND CHINA INSULIN PUMPS MARKET BY VENDOR RANKING, 2016 57

TABLE 11 INSULET CORP.: PRODUCT OFFERINGS 61

TABLE 12 INSULET CORP.: RECENT DEVELOPMENTS 61

TABLE 13 MEDTRONIC PLC: OFFERINGS 66

TABLE 14 MEDTRONIC PLC: RECENT DEVELOPMENTS 66

TABLE 15 MICROPORT SCIENTIFIC: OFFERINGS 79

TABLE 16 MICROPORT SCIENTIFIC CORPORATION: RECENT DEVELOPMENTS 79

TABLE 17 F. HOFFMANN-LA ROCHE: OFFERINGS 85

TABLE 18 F. HOFFMANN-LA ROCHE.: RECENT DEVELOPMENTS 85

TABLE 19 TANDEM DIABETES CARE, INC: RECENT DEVELOPMENTS 93

TABLE 20 TANDEM DIABETES CARE, INC: RECENT DEVELOPMENTS 93

TABLE 21 ELI LILLY AND COMPANY: SNAPSHOT 97

TABLE 22 ELI LILLY AND COMPANY: RECENT DEVELOPMENTS 97

TABLE 23 ANIMAS CORP.: RECENT DEVELOPMENTS 99

TABLE 24 SOOIL DEVELOPMENT CO., LTD.: SNAPSHOT 101

TABLE 25 SOOIL DEVELOPMENT CO., LTD.: RECENT DEVELOPMENTS 101

TABLE 26 YPSOMED HOLDING AG: SNAPSHOT 101

TABLE 27 YPSOMED HOLDING AG: RECENT DEVELOPMENTS 102

TABLE 28 VALERITAS, INC: SNAPSHOT 102

TABLE 29 VALERITAS, INC: RECENT DEVELOPMENTS 103

TABLE 30 GLYSENS ICGM: SNAPSHOT 103

TABLE 31 GLYSENS ICGMS: RECENT DEVELOPMENTS 103

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Insulet Corp., Medtronic plc, MicroPort Scientific Corp., F. Hoffmann-La Roche (Roche) Ltd., Tandem Diabetes Care, and other predominate & niche players